Bortezomib-induced Apoptosis in the Treatment of Non-small Cell Lung Cancer


Lung cancer, which can be classified into nonsmall cell lung cancer (NSCLC) and small cell lung cancer (SCLC), is the leading cause of cancerrelated death in the world. NSCLC, which accounts for 80 to 85% of all lung cancers, is distinguished from SCLC by its clinical course and its response to chemotherapy and radiotherapy. More than 70% of NSCLC patients… (More)


1 Figure or Table